Foghorn Therapeutics Inc. (FHTX) has a market capitalization of $284.7M and trades at $4.85. The 52-week range is 3-6.95.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.1, Earnings Per Share (EPS) of $-1.18, annual revenue of $30.91M.
The stock has a beta of 3.11, operates in the Healthcare sector.
